Metabolic associated fatty liver disease and COVID-19: a double whammy?

Metabolic associated fatty liver disease and COVID-19: a double whammy?

Saved in:

Bibliographic Details
Main Authors:	Jaime Hui Xian Lin, Veeraraghavan Meyyur Aravamudan
Format:	Article
Language:	English
Published:	Wolters Kluwer – Medknow Publications 2022-09-01
Series:	Singapore Medical Journal
Online Access:	https://journals.lww.com/10.11622/smedj.2020141
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

Association between TyG related parameters and metabolic dysfunction associated fatty liver disease among nondiabetic individuals
by: Qian Zhang, et al.
Published: (2025-02-01)

Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes
by: Amedeo Lonardo
Published: (2023-08-01)

AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease
by: Lulu Zhang, et al.
Published: (2025-02-01)

Effects of time restricted feeding combined with Lacto Ovo vegetarian diet on metabolic associated fatty liver disease management: a randomized clinical trial
by: Mahshad Shafiee, et al.
Published: (2025-02-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study
by: Hui Liu, et al.
Published: (2025-01-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

New aspects of non-alcoholic fatty liver disease
by: V. V. Tsukanov, et al.
Published: (2015-09-01)

Associations between brominated flame retardants exposure and non-alcoholic fatty liver disease: Mediation analysis in the NHANES
by: Yulan Cheng, et al.
Published: (2025-01-01)

Diagnostics and treatment of non-alcoholic fatty liver disease: clinical guidelines of the Russian Scientific Liver Society and the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2016-08-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

Options of dyslipidemia treatment at non-alcoholic fatty liver disease
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Pathogenic role of lipids in non-alcoholic fatty liver disease
by: Yu. O. Shulpekova
Published: (2012-02-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Preventive role of Pastinaca sativa in mitigating metabolic dysfunction-associated steatotic liver disease via modulation of metabolic endotoxemia
by: Ji-Eun Park, et al.
Published: (2025-02-01)

Metabolism of bile acids, liver diseases and microbiome
by: Yu. V. Yevsyutina, et al.
Published: (2018-08-01)

Association of leptin receptor Gln223Arg genetic polymorphism with obesity and non-alcoholic fatty liver disease
by: A. V. Morozova, et al.
Published: (2014-09-01)

Association between sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis
by: Kasra Pirahesh, et al.
Published: (2025-02-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity
by: I. V. Logacheva, et al.
Published: (2019-01-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Electrical and Viscoelastic Parameters of Erythrocytes as a Part of Diagnostic Models for Differentiating Fatty Liver Disease of Mixed Genesis from Non-Alcoholic and Alcohol-Related Fatty Liver Disease
by: M. V. Kruchinina, et al.
Published: (2024-08-01)

Impaired RelA signaling and lipid metabolism dysregulation in hepatocytes: driving forces in the progression of metabolic dysfunction-associated steatotic liver disease
by: Yihuai He, et al.
Published: (2025-02-01)

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01)

Association of high-sensitivity C-reactive protein with hepatic fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
by: Yunfei Wu, et al.
Published: (2025-02-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Association between prognostic nutritional index and all-cause mortality and cardiovascular disease mortality in American adults with non-alcoholic fatty liver disease
by: Yuqing Lei, et al.
Published: (2025-02-01)

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
by: Ye. N. Shirokova
Published: (2023-08-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: A. E. Bagriy, et al.
Published: (2021-06-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

Assessment of ChatGPT-generated medical Arabic responses for patients with metabolic dysfunction-associated steatotic liver disease.
by: Saleh A Alqahtani, et al.
Published: (2025-01-01)

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease
by: T. S. Krolevets, et al.
Published: (2020-12-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
by: Bin Liang, et al.
Published: (2025-02-01)

Genome-wide association study of the fatty liver index in the Taiwanese population reveals shared and population-specific genetic risk factors across ethnicities
by: Pei Pei Lau, et al.
Published: (2025-02-01)

The association between serum fructosamine and random spot urine fructose levels with the severity of non-alcoholic fatty liver disease – an analytical cross-sectional study
by: H Kamuzinzi, et al.
Published: (2024-05-01)

The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity
by: N. L. Denisov, et al.
Published: (2018-08-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)